Trial Profile
Macitentan treatment in patients with pulmonary arterial hypertension previously treated with bosentan
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Nov 2015
Price :
$35
*
At a glance
- Drugs Macitentan (Primary) ; Bosentan
- Indications Pulmonary arterial hypertension
- Focus Adverse reactions; Therapeutic Use
- 12 Nov 2015 New trial record